Source: International Journal of Nanomedicine. Unidades: FCF, FM
Subjects: NANOPARTÍCULAS, INFARTO DO MIOCÁRDIO, ADENOSINA, FARMACOCINÉTICA
ABNT
MARANHÃO, Raul Cavalcante et al. Methotrexate carried in lipid core nanoparticles reduces myocardial infarction size and improves cardiac function in rats. International Journal of Nanomedicine, v. 12, p. 3767-3784, 2017Tradução . . Disponível em: https://doi.org/10.2147/IJN.S129324. Acesso em: 16 ago. 2024.APA
Maranhão, R. C., Guido, M. C., Lima, A. D. de, Tavares, E. R., Marques, A. F., Melo, M. D. T. de, et al. (2017). Methotrexate carried in lipid core nanoparticles reduces myocardial infarction size and improves cardiac function in rats. International Journal of Nanomedicine, 12, 3767-3784. doi:10.2147/IJN.S129324NLM
Maranhão RC, Guido MC, Lima AD de, Tavares ER, Marques AF, Melo MDT de, Nicolau JC, Salemi VMC, Kalil Filho R. Methotrexate carried in lipid core nanoparticles reduces myocardial infarction size and improves cardiac function in rats [Internet]. International Journal of Nanomedicine. 2017 ; 12 3767-3784.[citado 2024 ago. 16 ] Available from: https://doi.org/10.2147/IJN.S129324Vancouver
Maranhão RC, Guido MC, Lima AD de, Tavares ER, Marques AF, Melo MDT de, Nicolau JC, Salemi VMC, Kalil Filho R. Methotrexate carried in lipid core nanoparticles reduces myocardial infarction size and improves cardiac function in rats [Internet]. International Journal of Nanomedicine. 2017 ; 12 3767-3784.[citado 2024 ago. 16 ] Available from: https://doi.org/10.2147/IJN.S129324